<?xml version="1.0" encoding="UTF-8"?>
<p>In this test, the temporal course curves of the shaking behavior in rats receiving the essential oil showed a significant reduction at doses of 10 and 31.62 mg/kg in neurogenic and inflammatory phases of the formalin (
 <xref ref-type="fig" rid="molecules-25-00675-f003">Figure 3</xref>A–C) (time: F
 <sub>6,174</sub> = 34.74, 
 <italic>p</italic> &lt; 0.0001; treatment: F
 <sub>4,29</sub> = 11.77, 
 <italic>p</italic> &lt; 0.0001; interaction: F
 <sub>24,174</sub> = 5.23, 
 <italic>p</italic> &lt; 0.0001). No significant diminution was observed in the dosage of 3.16 mg/kg of this treatment (
 <xref ref-type="fig" rid="molecules-25-00675-f003">Figure 3</xref>A–C), whereas a significant and dose-dependent response in the neurogenic phase between doses of 10 and 31.62 mg/kg, i.p. allowed determining a half-maximal effective dose (ED
 <sub>50</sub>) = 14.54 mg/kg, i.p. (F
 <sub>4,30</sub> = 6.12, 
 <italic>p</italic> = 0.001) (
 <xref ref-type="fig" rid="molecules-25-00675-f003">Figure 3</xref>C). On the other hand, a significant but non-dose-dependent effect was obtained in the inflammatory stage (F
 <sub>4,30</sub> = 6.02, 
 <italic>p</italic> = 0.001) (
 <xref ref-type="fig" rid="molecules-25-00675-f003">Figure 3</xref>C). 
</p>
